Cargando…
The oncologic and safety outcomes of low-dose-rate brachytherapy for the treatment of prostate cancer
Around 40 years have passed since a modern low-dose-rate (LDR) brachytherapy for prostate cancer was introduced. LDR brachytherapy has become one of the definitive treatment options besides radical prostatectomy (RP) and external beam radiation therapy (EBRT). LDR brachytherapy has several advantage...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Asian Pacific Prostate Society
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10513906/ https://www.ncbi.nlm.nih.gov/pubmed/37745911 http://dx.doi.org/10.1016/j.prnil.2023.01.004 |